Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.37 | N/A |
| PEG Ratio (TTM) | -1.47 | N/A |
| P/S Ratio (TTM) | 2.35 | N/A |
| P/B Ratio (TTM) | 1.19 | N/A |
| P/FCF Ratio (TTM) | 23.62 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.07% | N/A |
| ROE (TTM) | 8.63% | N/A |
| Net Profit Margin (TTM) | 15.68% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -8.69% | 89.76% | N/A |
| Revenue | 0.24% | 7.00% | N/A |
| Net Income | -7.30% | 59.17% | N/A |
| Cash Flow | -97.03% | 321.17% | N/A |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 50.14 | N/A |
| Quick Ratio (TTM) | 50.14 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | 0.95 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.26 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |